A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC). (2019)

First Author: Woodcock V

Attributed to: MICA: Study of disease mechanisms in enteric fever to characterise innate & adaptive immunity in mucosa & blood in controlled human infection model funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Journal of Clinical Oncology

Issue: 7_suppl